Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of β-catenin protein level.
暂无分享,去创建一个
Sherine M Rizk | A. Fawzy | A. Abulsoud | Mai A. Abd-Elmawla | M. Bakr | Hanan Elimam | H. G. El-Din
[1] O. Shaker,et al. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights. , 2023, ACS chemical neuroscience.
[2] He Hu,et al. Long non‐coding RNA telomerase RNA elements improve glucocorticoid‐induced osteoporosis by EZH2 to regulate DKK1 , 2023, International journal of rheumatic diseases.
[3] Mai A. Abd-Elmawla,et al. LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus. , 2022, Life sciences.
[4] T. Levin,et al. Current and future colorectal cancer screening strategies , 2022, Nature Reviews Gastroenterology & Hepatology.
[5] N. Shrivastava,et al. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis , 2022, Comput. Biol. Medicine.
[6] P. Ji,et al. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma , 2022, Journal of immunology research.
[7] M. Fabbri,et al. Noncoding RNA therapeutics — challenges and potential solutions , 2021, Nature reviews. Drug discovery.
[8] Z. Zhou,et al. Structures of telomerase at several steps of telomere repeat synthesis , 2021, Nature.
[9] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[10] Yan Zeng,et al. Comprehensive analysis of lncRNAs N6-methyladenosine modification in colorectal cancer , 2021, Aging.
[11] A. Kourtidis,et al. LNCcation: lncRNA localization and function , 2021, The Journal of cell biology.
[12] Kavita Gala,et al. Long non-coding RNAs at work on telomeres: Functions and implications in cancer therapy. , 2021, Cancer letters.
[13] Maite Huarte,et al. Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.
[14] H. Clevers,et al. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation , 2020, Nature Communications.
[15] M. Gorospe,et al. Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging. , 2020, Trends in molecular medicine.
[16] Wei Xu,et al. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer , 2020, International journal of cancer.
[17] D. Chung,et al. Pathways of Colorectal Carcinogenesis. , 2020, Gastroenterology.
[18] I. Csabai,et al. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition , 2019, BMC Cancer.
[19] R. Wada,et al. In vitro and in vivo studies on the association of long non‑coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5‑fluorouracil in rectal cancer. , 2019, International Journal of Oncology.
[20] E. Giovannucci,et al. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.
[21] W. Zhuo,et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. , 2019, American journal of cancer research.
[22] L. Floeter-Winter,et al. Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease , 2019, Non-coding RNA.
[23] M. Oshima,et al. Mutant p53 in colon cancer , 2018, Journal of molecular cell biology.
[24] Na-Na Guan,et al. Computational models for lncRNA function prediction and functional similarity calculation , 2018, Briefings in functional genomics.
[25] Qingsheng Li,et al. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway. , 2018, Biochemical and biophysical research communications.
[26] M. Weiser,et al. AJCC 8th Edition: Colorectal Cancer , 2018, Annals of Surgical Oncology.
[27] I. Komuro,et al. Heart Failure as an Aging-Related Phenotype. , 2018, International heart journal.
[28] A. D. De Marzo,et al. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer , 2018, The Journal of pathology.
[29] Xiang Yu,et al. Identification of dysregulated lncRNAs profiling and metastasis‐associated lncRNAs in colorectal cancer by genome‐wide analysis , 2017, Cancer medicine.
[30] A. Bhan,et al. Long Noncoding RNA and Cancer: A New Paradigm. , 2017, Cancer research.
[31] D. Glavač,et al. Long Noncoding RNAs as Biomarkers in Cancer , 2017, Disease markers.
[32] M. Qazi,et al. Non-coding RNAs in cancer diagnosis and therapy , 2016, Non-coding RNA research.
[33] Y. Jo,et al. Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer , 2016, Molecular and Cellular Endocrinology.
[34] Ahmedin Jemal,et al. Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.
[35] Alessio Colantoni,et al. Revealing protein–lncRNA interaction , 2015, Briefings Bioinform..
[36] Maite Huarte. The emerging role of lncRNAs in cancer , 2015, Nature Medicine.
[37] M. Varella‐Garcia,et al. MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non–small Cell Lung Cancer , 2015, American journal of clinical oncology.
[38] David A. Williams,et al. Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy. , 2014, Cell stem cell.
[39] Chunnian He,et al. Genomic Amplification of hTERC in Paraffin-embedded Tissues of Cervical Intraepithelial Neoplasia and Invasive Cancer , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[40] Lei Wang,et al. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells , 2011, Medical oncology.
[41] C. Compton,et al. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.
[42] Sandy Chang,et al. Telomere dysfunction and tumour suppression: the senescence connection , 2008, Nature Reviews Cancer.
[43] M. Blasco,et al. The longest telomeres: a general signature of adult stem cell compartments. , 2008, Genes & development.
[44] A. Wright,et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis , 2008, Aging cell.
[45] Hongying Wang,et al. Overexpressed beta-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells. , 2005, Cancer research.
[46] E. Blackburn,et al. Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA* , 2005, Journal of Biological Chemistry.
[47] S. Novaković,et al. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. , 2004, Oncology reports.
[48] Y. Kondo,et al. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. , 2000, Cancer research.
[49] R. Silverman,et al. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. , 2000, Gynecologic oncology.
[50] M. Blasco,et al. Impaired germinal center reaction in mice with short telomeres , 2000, The EMBO journal.
[51] R. Silverman,et al. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA , 1998, Oncogene.
[52] María A Blasco,et al. Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.
[53] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[54] et al.,et al. The RNA component of human telomerase , 1995, Science.